Librería: Chiron Media, Wallingford, Reino Unido
EUR 64,67
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardcover. Condición: New.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 78,92
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp.
Idioma: Inglés
Publicado por Elsevier - Health Sciences Division, 2015
ISBN 10: 0323402429 ISBN 13: 9780323402422
Librería: Revaluation Books, Exeter, Reino Unido
EUR 75,33
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 9.13x6.57x1.11 inches. In Stock.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 92,44
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 88,83
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp.
Idioma: Inglés
Publicado por Elsevier - Health Sciences Division, 2016
ISBN 10: 0323402429 ISBN 13: 9780323402422
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 81,81
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. New copy - Usually dispatched within 4 working days.
Idioma: Inglés
Publicado por Elsevier - Health Sciences Division, 2015
ISBN 10: 0323402429 ISBN 13: 9780323402422
Librería: Buchpark, Trebbin, Alemania
EUR 60,54
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 77,17
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Elsevier Health Science, Elsevier, 2016
ISBN 10: 0323402429 ISBN 13: 9780323402422
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 75,99
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Heart failure is the only cardiovascular disease that is increasing. The impact on the critical care environment and the health care system, as a whole, is significant from both a cost and burden to the system perspective. There are 6.5 million hospital days a year and nearly $40 billion dollars in yearly health care costs attributed to heart failure in the United States. There are more Medicare monies spent for diagnosing and treating heart failure than any other Diagnosis Related Group. There is a 24% hospital re-admission rate for this diagnosis which leads to financial implications for health care systems.The human cost is also significant. Less than half of Americans diagnosed with heart failure survive greater than 5 years. The ongoing health care needs and cost of this chronic disease takes a significant toll on patients' finances, time and quality of life. Over $2.9 billion dollars is spent annually on the pharmaceutical management of heart failure in the United States. This diagnosis is the leading cause of hospitalization for patients who are 65 years of age and older. Few health care providers in the critical care environment are not affected by heart failure on a routine basis. Caring for these patients and their families is both a challenging and yet a rewarding experience. This edition will provide critical care nurses with a comprehensive heart failure review which is essential in caring for this challenging population given the dynamic health and critical care environments. Englisch.
Idioma: Inglés
Publicado por Elsevier Health Science, Elsevier, 2016
ISBN 10: 0323402429 ISBN 13: 9780323402422
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 84,27
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Heart failure is the only cardiovascular disease that is increasing. The impact on the critical care environment and the health care system, as a whole, is significant from both a cost and burden to the system perspective. There are 6.5 million hospital days a year and nearly $40 billion dollars in yearly health care costs attributed to heart failure in the United States. There are more Medicare monies spent for diagnosing and treating heart failure than any other Diagnosis Related Group. There is a 24% hospital re-admission rate for this diagnosis which leads to financial implications for health care systems.The human cost is also significant. Less than half of Americans diagnosed with heart failure survive greater than 5 years. The ongoing health care needs and cost of this chronic disease takes a significant toll on patients' finances, time and quality of life. Over $2.9 billion dollars is spent annually on the pharmaceutical management of heart failure in the United States. This diagnosis is the leading cause of hospitalization for patients who are 65 years of age and older. Few health care providers in the critical care environment are not affected by heart failure on a routine basis. Caring for these patients and their families is both a challenging and yet a rewarding experience. This edition will provide critical care nurses with a comprehensive heart failure review which is essential in caring for this challenging population given the dynamic health and critical care environments.